Sundrug CoSDGCF 75 Return-on-Tangible-Asset is 6.11% as of Mar. 2026, which is 25% below its 10-year median of 8.18. GuruFocus rates SDGCF with a GF Score™ of 75/100 and a GF Value™ of $34.88. The stock has 1 warning sign investors should review. Among 683 Healthcare Providers & Services companies, Sundrug Co ranks better than 71.01% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Sundrug Co's annualizedNet Income for the quarter that ended in Mar. 2026 was $181 Mil. Sundrug Co's average total tangible assets for the quarter that ended in Mar. 2026 was $2,954 Mil. Therefore, Sundrug Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 6.11%.
The historical rank and industry rank for Sundrug Co's Return-on-Tangible-Asset or its related term are showing as below:
SDGCF'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 6.95 Med: 8.18 Max: 10.88
Current: 7.01
During the past 13 years, Sundrug Co's highest Return-on-Tangible-Asset was 10.88%. The lowest was 6.95%. And the median was 8.18%.
SDGCF's Return-on-Tangible-Asset is ranked better than 71.01% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 2.43
vs SDGCF: 7.01
Sundrug Co (OTCPK:SDGCF) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Sundrug Co Return-on-Tangible-Asset Related Terms
Sundrug Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Sundrug Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co Return-on-Tangible-Asset Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sundrug Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Sundrug Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 6.11% mean?
Sundrug Co (SDGCF) has a Return-on-Tangible-Asset of 6.11% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sundrug Co and its competitors. This is 25% below median its historical median of 8.18. Over the past decade, Sundrug Co's Return-on-Tangible-Asset has ranged from 6.95 to 10.88. According to the industry distribution chart, Sundrug Co ranks #198 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 29%.
Is Sundrug Co's Return-on-Tangible-Asset too high?
Sundrug Co's current Return-on-Tangible-Asset of 6.11% is 25% below median its 10-year median of 8.18. Over the past 10 years, this metric has ranged from a low of 6.95 to a high of 10.88. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.43. Sundrug Co's value of 6.11% is 151.4% above this industry median. Based on the distribution chart, Sundrug Co ranks #198 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sundrug Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #198 out of 683 companies for Return-on-Tangible-Asset. This puts Sundrug Co in the upper half of its industry. The industry median Return-on-Tangible-Asset is 2.43. Sundrug Co's value of 6.11% is 151.4% above this benchmark. Historically, Sundrug Co's own Return-on-Tangible-Asset has ranged from 6.95 to 10.88 over the past decade. While the company's 10-year median is 8.18 vs. the industry median of 2.43, Sundrug Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current Return-on-Tangible-Asset of 6.11% is 151.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current Return-on-Tangible-Asset is 6.11%, which is 25% below median its own 10-year median of 8.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Sundrug Co (SDGCF) has a current Return-on-Tangible-Asset of 6.11%. The stock's GF Value™ is $34.88, compared to a current price of $28.18 — trading 19.2% below its estimated fair value. The current Return-on-Tangible-Asset is 6.11%, which is 25% below median its 10-year median of 8.18 and 151.4% above the Healthcare Providers & Services industry median of 2.43. Sundrug Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Sundrug Co (SDGCF), the current Return-on-Tangible-Asset is 6.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (SDGCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of $28.18 is trading 19.2% below its estimated GF Value™ of $34.88.
Key valuation signals for SDGCF:
Return-on-Tangible-Asset: 6.11% (25% below median its 10-year median of 8.18)
GF Value™: $34.88 vs. price of $28.18 (19.2% below fair value)
Industry Position: 151.4% above the Healthcare Providers & Services median (#198 of 683)
No single metric tells the full story. See the SDGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
75GF Score
Get the complete analysis for SDGCF
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDGCF has been successfully added to your 
